Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: Clinical trial for chronic skin ulcers

Tissue Engineering - Part A

Volumn 19, Issue 17-18, 2013, Pages 1931-1940

  Morimoto, Naoki ^a,b   Yoshimura, Kenichi ^c   Niimi, Miyuki ^c   Ito, Tatsuya ^c   Aya, Rino ^a   Fujitaka, Junpei ^a   Tada, Harue ^c   Teramukai, Satoshi ^c   Murayama, Toshinori ^c   Toyooka, Chikako ^c   Miura, Kazumi ^c   Takemoto, Satoru ^a   Kanda, Norikazu ^a   Kawai, Katsuya ^a   Yokode, Masayuki ^c   Shimizu, Akira ^c   Suzuki, Shigehiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; EXPERIMENTS; MEDICAL APPLICATIONS; SCAFFOLDS;

BASIC FIBROBLAST GROWTH FACTOR; CAUSAL RELATIONSHIPS; COMBINATION THERAPY; DIABETIC ULCERS; PROMISING THERAPY; SIGNIFICANT DIFFERENCES; SUSTAINED RELEASE; VENOUS LEG ULCERS;

PATIENT TREATMENT;

ALANINE AMINOTRANSFERASE; CHOLINESTERASE; COLLAGEN; FIBROBLAST GROWTH FACTOR 2; GELATIN SPONGE; METHOTREXATE; PREDNISOLONE; SILICONE; GELATIN; TISSUE SCAFFOLD;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; COLLAGEN DISEASE; CORTICOSTEROID THERAPY; DEBRIDEMENT; DECUBITUS; DRUG MEGADOSE; EPITHELIZATION; FEMALE; GRANULATION TISSUE; HEMATOMA; HUMAN; INFECTION; LOW DRUG DOSE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PATIENT SAFETY; PERFUSION PRESSURE; PRIORITY JOURNAL; PRURITUS; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN ULCER; SUSTAINED DRUG RELEASE; ULCER; VACUUM ASSISTED CLOSURE; WOUND COMPLICATION; CHEMISTRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; RANDOMIZED CONTROLLED TRIAL; TISSUE SCAFFOLD;

ADULT; AGED; COLLAGEN; FEMALE; FIBROBLAST GROWTH FACTOR 2; GELATIN; HUMANS; MALE; MIDDLE AGED; SKIN ULCER; TISSUE SCAFFOLDS;

EID: 84881182007     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0634     Document Type: Article

References (40)

1. Vuorisalo, S., Venermo, M., and Lepäntalo, M. Treatment of diabetic foot ulcers. J Cardiovasc Surg (Torino) 50, 275, 2009
2. Bergqvist, D., Lindholm, C., and Nelzen, O. Chronic leg ulcers: The impact of venous disease. J Vasc Surg 29, 752, 1999
3. Singh, N., Armstrong, D.G., and Lipsky, B.A. Preventing foot ulcers in patients with diabetes. JAMA 293, 217, 2005
4. Wu, S.C., Driver, V.R., Wrobel, J.S., and Armstrong, D.G. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 3, 65, 2007
5. Milic, D.J., Zivic, S.S., Bogdanovic, D.C., Karanovic, N.D., and Golubovic, Z.V. Risk factors related to the failure of venous leg ulcers to heal with compression treatment. J Vasc Surg 49, 1242, 2009
6. Cavorsi, J., Vicari, F., Wirthlin, D.J., Ennis, W., Kirsner, R., O'Connell, S.M., Steinberg, J., and Falanga, V. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers. Wound Repair Regen 14, 102, 2006
7. Ehrenreich, M., and Ruszczak, Z. Update on tissueengineered biological dressings. Tissue Eng 12, 2407, 2006
8. Mason, C., and Manzotti, E. Regenerative medicine cell therapies: Numbers of units manufactured and patients treated between 1988 and 2010. Regen Med 5, 307, 2010
9. Hanson, S.E., Bentz, M.L., and Hematti, P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg 125, 510, 2010
10. Falanga, V., Iwamoto, S., Chartier, M., Yufit, T., Butmarc, J., Kouttab, N., Shrayer, D., and Carson, P. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 13, 1299, 2007
11. Langer, A., and Rogowski, W. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res 10, 115, 2009
12. Steed, D.L. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 117, 143S, 2006
13. Tuyet, H.L., Nguyen Quynh, T.T., Vo Hoang Minh, H., Thi Bich, D.N., Do Dinh, T., Le Tan, D., Van, H.L., Le Huy, T., Doan Huu, H., and Tran Trong, T.N. The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: The preliminary results. Int Wound J 6, 159, 2009
14. Uchi, H., Igarashi, A., Urabe, K., Koga, T., Nakayama, J., Kawamori, R., Tamaki, K., Hirakata, H., Ohmura, T., and Furue, M. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 19, 461, 2009
15. Gospodarowicz, D. Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249, 123, 1974
16. Akita, S., Akino, K., Imaizumi, T., and Hirano, A. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen 16, 635, 2008
17. Muneuchi, G., Suzuki, S., Moriue, T., and Igawa, H.H. Combined treatment using artificial dermis and basic fibroblast growth factor (bFGF) for intractable fingertip ulcers caused by atypical burn injuries. Burns 31, 514, 2005
18. Akita, S., Akino, K., Tanaka, K., Anraku, K., and Hirano, A.A. basic fibroblast growth factor improves lower extremity wound healing with a porcine-derived skin substitute. J Trauma 64, 809, 2008
19. Ito, K., Ito, S., Sekine, M., and Abe, M. Reconstruction of the soft tissue of a deep diabetic foot wound with artificial dermis and recombinant basic fibroblast growth factor. Plast Reconstr Surg 115, 562, 2005
20. Takemoto, S., Morimoto, N., Kimura, Y., Taira, T., Kitagawa, T., Tomihata, K., Tabata, Y., and Suzuki, S. Preparation of collagen/gelatin sponge scaffold for sustained release of bFGF. Tissue Eng Part A 14, 1629, 2008
21. Kanda, N., Morimoto, N., Ayvazyan, A.A., Takemoto, S., Kawai, K., Nakamura, Y., Sakamoto, Y., Taira, T., and Suzuki, S. Evaluation of a novel collagen-gelatin scaffold for achieving the sustained release of basic fibroblast growth factor in a diabetic mouse model. J Tissue Eng Regen Med 2012 [Epub ahead of print]; DOI: 10.1002/term.1492
22. Ayvazyan, A.,Morimoto, N., Kanda, N., Takemoto, S., Kawai, K., Sakamoto, Y., Taira, T., and Suzuki, S. Collagen-gelatin scaffold impregnated with bFGF accelerates palatal wound healing of palatal mucosa in dogs. J Surg Res 171, e247, 2011
23. Kanda, N., Morimoto, N., Takemoto, S., Ayvazyan, A.A., Kawai, K., Sakamoto, Y., Taira, T., and Suzuki, S. Efficacy of novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor for dermis-like tissue regeneration. Ann Plast Surg Jul 5, 2011
24. Morimoto, N., Yoshimura, K., Niimi, M., Ito, T., Tada, H., Teramukai, S., Murayama, T., Toyooka, C., Takemoto, S., Kawai, K., Yokode, M., Shimizu, A., and Suzuki, S. An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: A study protocol. Am J Transl Res 4, 52, 2012
25. Suzuki, S., Matsuda, K., Issiki, N., Tamada, Y., and Ikada, Y. Experimental study of a newly developed bilayer artificial skin. Biomaterials 11, 356, 1990
26. Yannas, I.V., Orgill, D.P., and Burke, J.F. Template for skin regeneration. Plast Reconstr Surg 127, 60S, 2011
27. Shaw, T.J., and Martin, P. Wound repair at a glance. J Cell Sci 122, 3209, 2009
28. Martin, P. Wound healing - aiming for perfect skin regeneration. Science 276, 75, 1997
29. Wong, T., McGrath, J.A., and Navsaria, H. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 156, 1149, 2007
30. Sanada, H., Moriguchi, T., Miyachi, Y., Ohura, T., Nakajo, T., Tokunaga, K., Fukui, M., Sugama, J., and Kitagawa, A. Reliability and validity of DESIGN, a tool that classifies pressure ulcer severity and monitors healing. J Wound Care 13, 13, 2004
31. Japanese Society of Pressure Ulcers. Guideline for Local Treatment of Pressure Ulcers, Japan: Shorinsha, 2005
32. Veves, A., Falanga, V., Armstrong, D.G., and Sabolinski, M.L. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial. Diabetes Care 24, 290, 2001
33. Cardinal, M., Eisenbud, D.E., Armstrong, D.G., Zelen, C., Driver, V., Attinger, C., Phillips, T., and Harding, K. Serial surgical debridement: A retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen 17, 306, 2009
34. Armstrong, D.G., and Lavery, L.A. Negative pressure wound therapy after partial diabetic foot amputation: A multicentre, randomised controlled trial. Lancet 366, 1704, 2005
35. Lavery, L.A., Barnes, S.A., Keith, M.S., Seaman, J.W. Jr., and Armstrong, D.G. Prediction of healing for postoperative diabetic foot wounds based on early wound area progression. Diabetes Care 31, 26, 2008
36. Zaulyanov, L., and Kirsner, R.S. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers. Clin Interv Aging 2, 93, 2007
37. Marston, W.A., Hanft, J., Norwood, P., and Pollak, R. Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomized trial. Diabetes Care 26, 1701, 2003
38. Aiba-Kojima, E., Tsuno, N.H., Inoue, K., Matsumoto, D., Shigeura, T., Sato, T., Suga, H., Kato, H., Nagase, T., Gonda, K., Koshima, I., Takahashi, K., and Yoshimura, K. Characterization of wound drainage fluids as a source of soluble factors associated with wound healing: Comparison with platelet-rich plasma and potential use in cell culture. Wound Repair Regen 15, 511, 2007
39. Dionyssiou, D., Demiri, E., Foroglou, P., Cheva, A., Saratzis, N., Aivazidis, C., and Karkavelas, G. The effectiveness of intralesional injection of platelet-rich plasma in accelerating the healing of chronic ulcers. An experimental and clinical study. Int Wound J 2012 [Epub ahead of print]; DOI: 10.1111/j.1742-481X.2012.00996.x.
40. Martínez-Zapata, M.J., Martí-Carvajal, A., Solà , I., Bolibar, I., Angel Expó sito, J., Rodriguez, L., and García, J. Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: A systematic review. Transfusion 49, 44, 2009.